CeriBell, Inc. Increase (Decrease) in Contract with Customer, Liability
CeriBell, Inc. (CBLL) reported Increase (Decrease) in Contract with Customer, Liability of -$90.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-10
- CeriBell, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$77.00K, a 955.56% decline year-over-year.
- CeriBell, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$13.00K, a 114.94% decline year-over-year.
- CeriBell, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$37.00K.
- CeriBell, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$85.00K.
- CeriBell, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$26.00K.
- CeriBell, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$123.00K.
- CeriBell, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$93.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$90.00K 10-Q · filed 2026-08-10 | -$127.00K derived: sum of 3 quarters · filed 2026-08-10 | -$212.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$13.00K 10-Q · filed 2026-05-11 | -$50.00K derived: sum of 2 quarters · filed 2026-05-11 | -$135.00K derived: sum of 3 quarters · filed 2026-05-11 | -$126.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$122.00K derived: sum of 2 quarters · filed 2026-02-24 | -$113.00K derived: sum of 3 quarters · filed 2026-08-10 | -$26.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$76.00K derived: sum of 2 quarters · filed 2026-08-10 | $11.00K 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $96.00K 10-Q · filed 2026-08-10 | $85.00K derived: sum of 3 quarters · filed 2026-08-10 | -$126.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $87.00K 10-Q · filed 2026-05-11 | $76.00K derived: sum of 2 quarters · filed 2026-05-11 | -$135.00K derived: sum of 3 quarters · filed 2026-05-11 | -$32.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$222.00K derived: sum of 2 quarters · filed 2026-02-24 | -$119.00K derived: sum of 3 quarters · filed 2026-02-24 | -$123.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | -$211.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$108.00K derived: sum of 2 quarters · filed 2025-11-04 | -$112.00K 10-Q · filed 2025-11-04 | -$102.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $103.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $99.00K 10-Q · filed 2025-08-05 | $109.00K derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | -$4.00K 10-Q · filed 2025-05-08 | $6.00K derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$93.00K 10-K · filed 2025-02-25 | ||
| 2023-09-30 | -$103.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |